Tom Wilemon

January 22, 2024

Molecular profiles of tissue plus circulating tumor DNA can better guide cancer care

Vanderbilt research indicates that adding liquid biopsy testing for circulating tumor DNA mutations increases targetable mutation detection rates.

By Tom Wilemon
January 9, 2024

Chic Awearness supports mentoring program for ovarian cancer patients

Chic Awearness is now supporting two new ovarian cancer research initiatives at Vanderbilt University Medical Center and providing matching funding for a social worker to coordinate Woman to Woman, a peer mentoring program launched at VUMC in 2023.

By Tom Wilemon
January 4, 2024

Potential AML therapy induces leukemic stem cell death

Vanderbilt researchers are studying a potential therapy for acute myeloid leukemia that targets the residual leukemic stem cells in bone marrow after treatment that are responsible for relapses and drug resistance.

By Tom Wilemon
Authors on the study included, from left, Jennifer Pietenpol, PhD, Melinda Sanders, MD, Brian Lehmann, PhD, Vandana Abramson, MD, and Yu Shyr, PhD. (photo by Donn Jones)
December 15, 2023

Clinical trial shows efficacy for atezolizumab combined with carboplatin

By Tom Wilemon
Sam S. Chang, MD, MBA
December 14, 2023

Sam S. Chang recognized by the American Urological Association

The American Urological Association has announced that Vanderbilt’s Sam S. Chang, MD, MBA, is one of its 2024 award recipients.

By Tom Wilemon
The visit was the first time a group of Ukrainian oncologists came to VUMC to learn about cancer research and care.
November 30, 2023

Ukrainian oncologists visit Vanderbilt-Ingram Cancer Center

A group of Ukrainian oncologists recently visited Vanderbilt-Ingram Cancer Center where they toured research labs, observed tumor board meetings, met with several Vanderbilt oncologists, and attended the 23rd Annual Retreat for Cancer Biology.

By Tom Wilemon
October 26, 2023

Debra Friedman named deputy director of Vanderbilt-Ingram Cancer Center

Internationally recognized cancer survivorship expert Debra Friedman, MD, MS, has been named deputy director of Vanderbilt-Ingram Cancer Center
By Tom Wilemon
October 17, 2023

Vanderbilt-Ingram Cancer Center earns NCI Merit Award

Vanderbilt-Ingram Cancer Center has earned a Merit Extension Award from the National Cancer Institute in recognition of more than a decade of sustained exceptional progress.
By Tom Wilemon
October 12, 2023

Prostate cancer survivors symposium set for Nov. 11

Vanderbilt University Medical Center Department of Urology and Vanderbilt-Ingram Cancer Center are hosting a symposium for prostate cancer survivors and their families on Saturday, Nov. 11.
By Tom Wilemon
October 12, 2023

Symposium for patients, caregivers and family members offers important information on stomach cancer, Nov. 4

A Vanderbilt symposium on Nov. 4 offers detailed information for patients, caregivers and family members about stomach cancer.
By Tom Wilemon
October 5, 2023

Study validates pyrvinium as treatment to prevent stomach cancer

A Vanderbilt study found that a drug that has been used for decades for intestinal pinworms, can be repurposed as a preventative treatment for stomach cancer.
By Tom Wilemon
October 4, 2023

Vulnerability found in immunotherapy-resistant triple-negative breast cancer

Vanderbilt researchers have discovered a druggable target on natural killer cells that could potentially trigger a therapeutic response in patients with immunotherapy-resistant, triple-negative breast cancer.
By Tom Wilemon
1 … 4 5 6 7 8 … 36